Acadia Healthcare (NASDAQ:ACHC) Upgraded to “Overweight” at KeyCorp

Acadia Healthcare (NASDAQ:ACHC) was upgraded by analysts at KeyCorp from a “sector weight” rating to an “overweight” rating in a research report issued to clients and investors on Tuesday, Marketbeat reports. The firm currently has a $70.00 target price on the stock. KeyCorp’s target price suggests a potential upside of 55.14% from the company’s previous close. KeyCorp also issued estimates for Acadia Healthcare’s Q2 2025 earnings at $0.85 EPS and Q3 2025 earnings at $0.92 EPS.

A number of other equities analysts also recently commented on ACHC. Cantor Fitzgerald restated a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday. Royal Bank of Canada cut their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research note on Monday, November 18th. Barclays cut their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research note on Friday, November 22nd. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and raised their target price for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Trading Down 0.0 %

Acadia Healthcare stock opened at $45.12 on Tuesday. The firm has a 50-day moving average of $40.43 and a 200-day moving average of $58.28. Acadia Healthcare has a one year low of $36.50 and a one year high of $87.77. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The company has a market cap of $4.19 billion, a price-to-earnings ratio of 14.79, a P/E/G ratio of 1.77 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. During the same period in the prior year, the business posted $0.91 EPS. The company’s quarterly revenue was up 8.7% on a year-over-year basis. On average, equities analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds have recently bought and sold shares of ACHC. GAMMA Investing LLC increased its holdings in shares of Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after purchasing an additional 241 shares during the period. Commonwealth Equity Services LLC increased its holdings in shares of Acadia Healthcare by 3.5% during the second quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after purchasing an additional 257 shares during the period. Atria Investments Inc increased its holdings in shares of Acadia Healthcare by 4.7% during the third quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock worth $434,000 after purchasing an additional 308 shares during the period. KBC Group NV increased its stake in Acadia Healthcare by 14.4% in the third quarter. KBC Group NV now owns 2,688 shares of the company’s stock valued at $170,000 after acquiring an additional 338 shares during the last quarter. Finally, Tidal Investments LLC increased its stake in Acadia Healthcare by 7.9% in the third quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock valued at $296,000 after acquiring an additional 340 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.